Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This refers to a Phase 4 clinical trial (NCT00528177) conducted at Ullevaal University Hospital comparing the efficacy and safety of intravenous morphine versus intravenous oxycodone for postoperative pain management. The study specifically focused on women undergoing gynecological laparoscopic surgery, such as hysterectomy or myomectomy, to determine if oxycodone provides superior analgesia for visceral pain compared to morphine. Both drugs are small molecule opioid agonists; morphine primarily targets mu-opioid receptors, while oxycodone acts on both mu-opioid and potentially kappa-opioid receptors. The trial utilized patient-controlled analgesia (PCA) for 24 hours postoperatively to evaluate the comparative analgesic profiles and side effects of these two separate opioid treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morphine + oxycodone (Ullevål University Hospital).